CROWN BAUS CAPITAL CORP. (OTCMKTS:CBCA) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

0
CROWN BAUS CAPITAL CORP. (OTCMKTS:CBCA) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

CROWN BAUS CAPITAL CORP. (OTCMKTS:CBCA) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02.

On October 22, 2019, a shareholder holding majority voting power of the shares of the Company, by written consent, voted to elect Charles J.S. Kwon to the Company’s board of Directors.

On October 22, 2019, the Company received the resignation of Raymond C. Dabney as the Company’s President, Chief Executive Officer and Director. On the same date, the Company received the resignation of Robert Kane as the Company’s Chief Operating Officer and Director. The departure of Messrs. Dabney and Kane from the Company’s Board decreases the Company’ Board of Directors to 2 members.

Also on October 22, 2019, the Company appointed Charles J.S. Kwon as its President and Chief Executive Officer.

Mr. Kwon received his Business Diploma from the British Columbia Institute of Technology in 2002. Afterwards, he started his career in the capital markets as a trader. Then in 2006, as an Investment Advisor at Global Securities. For the past 5 years, Mr. Kwon has been a partner at ReThink, managing their Real Estate and Investment holdings. Mr. Kwon melds his experience in the capital market sector with business expertise, inspirational vision, fundraising experience and strategic focus.

Mr. Kwon will serve as a Company director and officer until his duly elected successor is appointed or his resignation. There are no arrangements or understandings between Mr. Kwon any other person to which he was selected as an officer or director. There are no family relationships between Mr. Kwon and any of the Company’s officers or directors. Mr. Kwon has not held any other directorships in a company with a class of securities registered to section 12 of the Exchange Act or subject to the requirements of section 15(d) of such Act or any company registered as an investment company under the Investment Company Act of 1940 during the past 5 years.

Effective October 22, 2019, the Company’s new address is Suite 205 – 2383 King George Blvd Surrey, British Columbia V4A 5A4 and the Company’s new phone number is 1-877-734-8420.


About CROWN BAUS CAPITAL CORP. (OTCMKTS:CBCA)

Crown Baus Capital Corporation is a global acquisition-based conglomerate targeting five primary industries: high-tech incubation, drug development, entertainment and media, education, and financial services. The Company specializes in the vertical integration of industrial, commercial and retail profit centers along with partnerships and start-ups. The Drug Development Division focuses on horticulture, laboratories, manufacturing, distribution, patient education and tracking. The Company focuses on global markets and participates in both national and state markets. The High-Tech Incubation Division is a resource for improving the technology business from the incubation stage, consulting and expanding the business. The Entertainment and Media Division focuses on providing resources for motion pictures, Web movies, and television. The Financial Services Division is focused on five points: process, economics, earnings, management and execution.